These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1794261)

  • 1. The treatment of NIDDM in the decade of the 90s.
    Krall LP
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S15-9. PubMed ID: 1794261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term comparison of oral hypoglycemic agents in diabetic retinopathy. Gliclazide vs. other sulfonylureas.
    Akanuma Y; Kosaka K; Kanazawa Y; Kasuga M; Fukuda M; Aoki S
    Diabetes Res Clin Pract; 1988 Jul; 5(2):81-90. PubMed ID: 3416710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of beta-cell function after long-term treatment with either insulin, insulin plus gliclazide or gliclazide in neonatal streptozotocin-induced non-insulin-dependent diabetic rats.
    Kawai K; Suzuki S; Murayama Y; Watanabe Y; Yamashita K
    Diabetes Res Clin Pract; 1991 Jul; 12(3):163-72. PubMed ID: 1832376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of non-insulin-dependent diabetes mellitus (type II): management with gliclazide.
    Rifkin H
    Am J Med; 1991 Jun; 90(6A):3S-7S. PubMed ID: 1872302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
    Portha B; Serradas P
    Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus.
    Palmer KJ; Brogden RN
    Drugs; 1993 Jul; 46(1):92-125. PubMed ID: 7691511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Insulinotropic effect of diamicron after oral fructose tolerance test in patients with non-insulin-dependent diabetes mellitus].
    Balabolkin MI; Levitskaia ZI; Morozova TP; Zhizhina SA; Gavriliuk LI
    Probl Endokrinol (Mosk); 1983; 29(5):8-12. PubMed ID: 6359134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gliclazide: metabolic and vascular effects--a perspective.
    Alberti KG; Johnson AB; Taylor R
    Metabolism; 1992 May; 41(5 Suppl 1):40-5. PubMed ID: 1574015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the efficacy and safety of Diamicron in non-insulin-dependent diabetic patients.
    Kilo C; Dudley J; Kalb B
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S79-82. PubMed ID: 1794270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfonylurea therapy improves glucose disposal without changing skeletal muscle GLUT4 levels in noninsulin-dependent diabetes mellitus subjects: a longitudinal study.
    Vestergaard H; Weinreb JE; Rosen AS; Bjørbaek C; Hansen L; Pedersen O; Kahn BB
    J Clin Endocrinol Metab; 1995 Jan; 80(1):270-5. PubMed ID: 7829624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.
    Rachman J; Levy JC; Barrow BA; Manley SE; Turner RC
    Diabetes; 1997 Oct; 46(10):1557-62. PubMed ID: 9313749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive and therapeutic effects of gliclazide on diabetic retinopathy: comparison with glibenclamide treatment.
    Minami N; Ikeda Y; Abe M
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():707-11. PubMed ID: 6440314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of newly diagnosed non-insulin-dependent diabetes mellitus in the primary care setting: effects of 2 years of gliclazide treatment--the Diadem Study.
    Cathelineau G; de Champvallins M; Bouallouche A; Lesobre B
    Metabolism; 1997 Dec; 46(12 Suppl 1):31-4. PubMed ID: 9439556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gliclazide and bedtime insulin are more efficient than insulin alone for type 2 diabetic patients with sulfonylurea secondary failure.
    Chazan AC; Gomes MB
    Braz J Med Biol Res; 2001 Jan; 34(1):49-56. PubMed ID: 11151028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gliclazide therapy of NIDDM in the 90s. Proceedings of 1st International Diamicron Symposium, September 24, 1990, Montreal, Canada.
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S1-92. PubMed ID: 1686583
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of 6-month gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM: role of initial continuous subcutaneous insulin infusion-induced normoglycemia.
    Della Casa L; del Rio G; Glaser B; Cerasi E
    Am J Med; 1991 Jun; 90(6A):37S-45S. PubMed ID: 1872303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative evaluation of the hypoglycemic effect of the 2d-generation sulfonylurea preparations maninil and diamicron in diabetes mellitus].
    Balabolkin MI; Morozova TP; Zhizhina SA; Levitskaia ZI; Gincherman LE
    Probl Endokrinol (Mosk); 1982; 28(5):9-11. PubMed ID: 6815639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gliclazide in the non-insulin-dependent diabetic patient in geriatrics].
    Frühwald T; Böhmer F
    Wien Med Wochenschr; 1988 Mar; 138(5):102-6. PubMed ID: 3388872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 6 months' gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM: role of initial CSII-induced normoglycemia.
    Della Casa L; del Rio G; Glaser B; Cerasi E
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S69-78. PubMed ID: 1794269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin: either alone or combined with oral hypoglycemic agents.
    Firth RG
    Prim Care; 1988 Sep; 15(3):665-83. PubMed ID: 3054969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.